Literature DB >> 29784079

Analgesic Efficacy and Safety of Hydromorphone in Chinchillas (Chinchilla lanigera).

Emily A Evenson1, Christoph Mans2.   

Abstract

Limited information is available regarding the efficacy of opioid analgesics in chinchillas. Here we sought to evaluate the analgesic efficacy and safety of hydromorphone in chinchillas. In a randomized, controlled, blind, complete crossover design, hydromorphone was administered at 0.5, 1, and 2 mg/kg SC to 16 chinchillas. Analgesic efficacy was determined by measuring hindlimb withdrawal latencies after a thermal noxious stimulus (Hargreaves method) at 0, 1, 2, 4, and 8 h after drug administration. Changes in daily food intake and fecal output after hydromorphone administration were recorded. At 2 mg/kg SC, but not at lower dosages, hydromorphone increased withdrawal latencies for less than 4 h. Food intake was reduced after all 3 dosages, and fecal output decreased in the 1- and 2-mg/kg groups. The decreases in these parameters were dose-dependent, with the greatest reduction measured over the first 24 h. Our current results indicate that hydromorphone at 2 mg/kg SC is an effective, short-acting analgesic drug in chinchillas that transiently reduces food intake and fecal output. Further studies are needed to evaluate the safety of hydromorphone in animals undergoing surgical procedures and general anesthesia and to determine whether lower doses provide analgesia in different nociceptive models.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29784079      PMCID: PMC5966236     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  22 in total

1.  ON THE ANALGESIC POWER OF MORPHINE IN RELATION TO AGE AND SEX OF GUINEA PIGS.

Authors:  E FROMMEL; E JOYE
Journal:  Med Exp Int J Exp Med       Date:  1964

Review 2.  Rodent analgesia.

Authors:  Amy L Miller; Claire A Richardson
Journal:  Vet Clin North Am Exot Anim Pract       Date:  2011-01

3.  A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain.

Authors:  Lesley J Smith; Janice R Valenzuela; Lisa A Krugner-Higby; Carolyn Brown; Timothy D Heath
Journal:  Comp Med       Date:  2006-12       Impact factor: 0.982

4.  Antinociceptive effects of sustained-release buprenorphine in a model of incisional pain in rats (Rattus norvegicus).

Authors:  Helen H Chum; Katechan Jampachairsri; Gabriel P McKeon; David C Yeomans; Cholawat Pacharinsak; Stephen A Felt
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-03       Impact factor: 1.232

5.  Pharmacokinetics and Paw Withdrawal Pressure in Female Guinea Pigs (Cavia porcellus) Treated with Sustained-Release Buprenorphine and Buprenorphine Hydrochloride.

Authors:  Brian J Smith; Daniel J Wegenast; Ryan J Hansen; Ann M Hess; Lon V Kendall
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-11       Impact factor: 1.232

Review 6.  Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals.

Authors:  J V Roughan; P A Flecknell
Journal:  Lab Anim       Date:  2002-07       Impact factor: 2.471

7.  Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation.

Authors:  Priyank Kumar; Soujanya Sunkaraneni; Sunil Sirohi; Shveta V Dighe; Ellen A Walker; Byron C Yoburn
Journal:  Eur J Pharmacol       Date:  2008-08-30       Impact factor: 4.432

8.  Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut.

Authors:  G Bianchi; P Ferretti; M Recchia; M Rocchetti; A Tavani; L Manara
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

Review 9.  Opioid receptors in the gastrointestinal tract.

Authors:  Peter Holzer
Journal:  Regul Pept       Date:  2009-04-02

Review 10.  Update on diseases of chinchillas.

Authors:  Christoph Mans; Thomas M Donnelly
Journal:  Vet Clin North Am Exot Anim Pract       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.